Search results for "ffpe challenges"
Selected Filters:
Getting organoids into the clinic
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
Revolutionize care with pioneering bispecific antibody therapy
Jiseon Kim, Senior Scientist at ProGen, explores the transformative potential of a bispecific antibody-based drug to lay the foundation for improved healthcare quality
Unlocking the potential of the multi-attribute method (MAM): The future of biopharma
New eBooks by Waters Corporation reveal the capabilities, adoption trends, and future of MAM for biotherapeutic analysis
Small molecule therapeutics continue to have a big impact on the pharmaceutical industry
Discover the latest technologies and methods advancing small molecule therapeutic discovery and development, from PROTAC quantification to microsampling innovations
Innovations in cell and gene therapy development and the technologies that have advanced the field
This special feature highlights interviews and resources about the latest advances in cell and gene therapy and the technologies behind them
Innovations that will revolutionize the future of PFAS analysis
Discover the most groundbreaking recent advancements in PFAS analysis and take a look forward to the developments set to shape the future of the field
How at-home blood tests power self-health management
Study shows accessible blood-biomarker insights and online coaching substantially improve health indicators
Cancer study emphasizes the need for non-targeted PFAS analysis
Non-targeted analysis (NTA) testing can help reveal the hidden dangers of 'forever chemicals’ following findings linking PFAS exposure to thyroid cancer
NexION® 2000 ICP Mass Spectrometer
PerkinElmerNexION 2000 ICP-MS – Triple-quad power meets single-quad versatility
Simplify volatiles analysis (Part 1): Why adopt direct MS in your lab or CRO?
Join us on Tuesday, September 15, for part one of the Syft Webinar Series on selected ion flow tube mass spectrometry
CytoSections: Validated Control for IHC, ISH, ICC
OriGene TechnologiesCytoSections is a verified, reproducible, and renewable positive control source where the target protein's expression is confirmed by western blot and IHC.
Atomic force microscopy for materials
Water needs in pharma quality control
How novel technologies are driving our understanding of the complex and dynamic nature of the human cell
SSci_CT_Manuel_Leonetti_Feb22_166_V2.txt
A simple quantitative method for monoclonal antibody coformulations
Analyzing Intact Peptides using LC-MS for Translational Research
Sysmex and Hitachi High-Tech agree to collaborate on development of new genetic testing systems
Collaboration aims to expand optimal genetic testing for individual diseases
5 upcoming webinars to broaden your research horizons
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on clinical diagnostics, cell and gene therapy, materials testing, and more
The future of drug discovery: Precision medicine through biomarker research
Discover how scientists at Medicine Discovery Catapult are using biomarkers to tailor approaches to patient care, in this exclusive interview with Dr. Sally Price